EP2604257

Oral transmucosal dosage forms comprising sufentanil and triazolam

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    7.8.2008
  • :
    28.6.2017
  • :
    13158781.8
  • :
    6.8.2028
  • :
    Oral transmucosal dosage forms comprising sufentanil and triazolam

7.8.2008
28.6.2017
  • :
    Acelrx Pharmaceuticals, Inc.
  • :
    575 Chesapeake Drive, 94063, Redwood City, CA, US
  • :
    Palmer, Pamela
  • :
    San Francisco, CA California, US
  • :
    Tzannis, Stelios
  • :
    Newark, CA California, US
  • :
    Schreck, Thomas
  • :
    Portola Valley, CA California, US
  • :
    954501 P
  • :
    7.8.2007
  • :
    US
  • :
    A61K 9/70, A61K 31/4535, A61K 31/5517, A61K 9/00, A61P 25/20